Filing Details
- Accession Number:
- 0001179110-16-021878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-17 20:23:21
- Reporting Period:
- 2016-03-15
- Filing Date:
- 2016-03-17
- Accepted Time:
- 2016-03-17 20:23:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187159 | Vincent Milano | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-15 | 40,000 | $1.97 | 246,527 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The transaction reported herein reflects an aggregate of purchases at per share prices ranging from $1.94 to $2.00 inclusive. The Reporting Person further undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the manner of shares purchased at each separate price.
- Includes 6,527 shares acquired under the IDRA employee stock purchase plan on February 29, 2016.
Billionaire Hedge Funds
